nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—asthma	0.374	0.889	CbGaD
Naloxone—ALB—asthma	0.0467	0.111	CbGaD
Naloxone—CYP2C8—Salmeterol—asthma	0.0185	0.054	CbGbCtD
Naloxone—CYP2C8—Mometasone—asthma	0.0185	0.054	CbGbCtD
Naloxone—ABCB1—Fluticasone furoate—asthma	0.0165	0.0482	CbGbCtD
Naloxone—SLCO1A2—Prednisolone—asthma	0.0156	0.0456	CbGbCtD
Naloxone—SLCO1A2—Hydrocortisone—asthma	0.0148	0.0432	CbGbCtD
Naloxone—SLCO1A2—Prednisone—asthma	0.0147	0.043	CbGbCtD
Naloxone—CYP2C8—Zafirlukast—asthma	0.0145	0.0424	CbGbCtD
Naloxone—ABCB1—Indacaterol—asthma	0.0134	0.0393	CbGbCtD
Naloxone—CYP2C8—Theophylline—asthma	0.0112	0.0327	CbGbCtD
Naloxone—CYP2C8—Montelukast—asthma	0.0106	0.031	CbGbCtD
Naloxone—CYP2C8—Loratadine—asthma	0.0106	0.031	CbGbCtD
Naloxone—CYP3A4—Fluticasone furoate—asthma	0.00988	0.0289	CbGbCtD
Naloxone—SLCO1A2—Dexamethasone—asthma	0.00919	0.0269	CbGbCtD
Naloxone—CYP3A4—Budesonide—asthma	0.00881	0.0257	CbGbCtD
Naloxone—CYP3A4—Indacaterol—asthma	0.00806	0.0235	CbGbCtD
Naloxone—CYP3A4—Ciclesonide—asthma	0.00806	0.0235	CbGbCtD
Naloxone—ALB—Prednisone—asthma	0.00761	0.0222	CbGbCtD
Naloxone—CYP3A4—Salbutamol—asthma	0.00749	0.0219	CbGbCtD
Naloxone—CYP3A4—Flunisolide—asthma	0.00749	0.0219	CbGbCtD
Naloxone—CYP3A4—Salmeterol—asthma	0.00749	0.0219	CbGbCtD
Naloxone—ABCB1—Loratadine—asthma	0.00718	0.021	CbGbCtD
Naloxone—CYP3A4—Zileuton—asthma	0.00668	0.0195	CbGbCtD
Naloxone—CYP3A4—Ipratropium bromide—asthma	0.00668	0.0195	CbGbCtD
Naloxone—ABCB1—Methylprednisolone—asthma	0.00657	0.0192	CbGbCtD
Naloxone—CYP3A4—Fluticasone Propionate—asthma	0.00637	0.0186	CbGbCtD
Naloxone—CYP2C8—Hydrocortisone—asthma	0.0059	0.0172	CbGbCtD
Naloxone—CYP3A4—Zafirlukast—asthma	0.00588	0.0172	CbGbCtD
Naloxone—CYP3A4—Tiotropium—asthma	0.00506	0.0148	CbGbCtD
Naloxone—CYP3A4—Aminophylline—asthma	0.00483	0.0141	CbGbCtD
Naloxone—CYP3A4—Theophylline—asthma	0.00454	0.0133	CbGbCtD
Naloxone—CYP3A4—Loratadine—asthma	0.0043	0.0126	CbGbCtD
Naloxone—CYP3A4—Montelukast—asthma	0.0043	0.0126	CbGbCtD
Naloxone—ABCB1—Betamethasone—asthma	0.00427	0.0125	CbGbCtD
Naloxone—ABCB1—Prednisolone—asthma	0.00421	0.0123	CbGbCtD
Naloxone—ABCB1—Hydrocortisone—asthma	0.00399	0.0117	CbGbCtD
Naloxone—ABCB1—Prednisone—asthma	0.00398	0.0116	CbGbCtD
Naloxone—CYP3A4—Methylprednisolone—asthma	0.00393	0.0115	CbGbCtD
Naloxone—CYP2C8—Dexamethasone—asthma	0.00367	0.0107	CbGbCtD
Naloxone—CYP3A4—Triamcinolone—asthma	0.00298	0.00872	CbGbCtD
Naloxone—CREB1—exocrine gland—asthma	0.00261	0.148	CbGeAlD
Naloxone—CYP3A4—Betamethasone—asthma	0.00256	0.00748	CbGbCtD
Naloxone—CYP3A4—Prednisolone—asthma	0.00252	0.00738	CbGbCtD
Naloxone—ABCB1—Dexamethasone—asthma	0.00248	0.00726	CbGbCtD
Naloxone—CYP3A4—Hydrocortisone—asthma	0.00239	0.00699	CbGbCtD
Naloxone—CYP3A4—Prednisone—asthma	0.00238	0.00697	CbGbCtD
Naloxone—TLR4—adrenal gland—asthma	0.00187	0.106	CbGeAlD
Naloxone—TLR4—lung—asthma	0.00164	0.0927	CbGeAlD
Naloxone—CYP3A4—Dexamethasone—asthma	0.00149	0.00435	CbGbCtD
Naloxone—CREB1—respiratory system—asthma	0.00136	0.0769	CbGeAlD
Naloxone—CREB1—epithelium—asthma	0.00114	0.0642	CbGeAlD
Naloxone—CREB1—bronchus—asthma	0.00112	0.0633	CbGeAlD
Naloxone—CREB1—smooth muscle tissue—asthma	0.00109	0.0619	CbGeAlD
Naloxone—CREB1—cardiovascular system—asthma	0.00104	0.0589	CbGeAlD
Naloxone—CREB1—adrenal gland—asthma	0.000824	0.0466	CbGeAlD
Naloxone—CREB1—lung—asthma	0.000722	0.0408	CbGeAlD
Naloxone—ESR1—respiratory system—asthma	0.000535	0.0303	CbGeAlD
Naloxone—ESR1—epithelium—asthma	0.000447	0.0253	CbGeAlD
Naloxone—ESR1—smooth muscle tissue—asthma	0.000431	0.0244	CbGeAlD
Naloxone—ESR1—cardiovascular system—asthma	0.00041	0.0232	CbGeAlD
Naloxone—ALB—adrenal gland—asthma	0.00038	0.0215	CbGeAlD
Naloxone—SLCO1A2—lung—asthma	0.000335	0.0189	CbGeAlD
Naloxone—ESR1—adrenal gland—asthma	0.000324	0.0183	CbGeAlD
Naloxone—ESR1—lung—asthma	0.000284	0.0161	CbGeAlD
Naloxone—ABCB1—respiratory system—asthma	0.000211	0.012	CbGeAlD
Naloxone—ABCB1—adrenal cortex—asthma	0.000177	0.01	CbGeAlD
Naloxone—ABCB1—epithelium—asthma	0.000177	0.00999	CbGeAlD
Naloxone—ABCB1—cardiovascular system—asthma	0.000162	0.00915	CbGeAlD
Naloxone—ABCB1—trachea—asthma	0.000156	0.00883	CbGeAlD
Naloxone—Abdominal pain—Salmeterol—asthma	0.000132	0.00121	CcSEcCtD
Naloxone—Body temperature increased—Salmeterol—asthma	0.000132	0.00121	CcSEcCtD
Naloxone—Nervousness—Budesonide—asthma	0.000131	0.0012	CcSEcCtD
Naloxone—Tremor—Salbutamol—asthma	0.000131	0.0012	CcSEcCtD
Naloxone—Diarrhoea—Cromoglicic acid—asthma	0.00013	0.00118	CcSEcCtD
Naloxone—Gastrointestinal disorder—Loratadine—asthma	0.000129	0.00118	CcSEcCtD
Naloxone—Nausea—Theophylline—asthma	0.000129	0.00118	CcSEcCtD
Naloxone—Nausea—Beclomethasone—asthma	0.000129	0.00118	CcSEcCtD
Naloxone—Gastrointestinal disorder—Tiotropium—asthma	0.000129	0.00118	CcSEcCtD
Naloxone—Agitation—Salbutamol—asthma	0.000128	0.00117	CcSEcCtD
Naloxone—Pain—Loratadine—asthma	0.000128	0.00117	CcSEcCtD
Naloxone—ABCB1—adrenal gland—asthma	0.000128	0.00724	CbGeAlD
Naloxone—Hypertension—Arformoterol—asthma	0.000128	0.00117	CcSEcCtD
Naloxone—Hypertension—Formoterol—asthma	0.000128	0.00117	CcSEcCtD
Naloxone—Tremor—Budesonide—asthma	0.000127	0.00116	CcSEcCtD
Naloxone—Cardiac arrest—Prednisolone—asthma	0.000126	0.00116	CcSEcCtD
Naloxone—Convulsion—Montelukast—asthma	0.000126	0.00115	CcSEcCtD
Naloxone—Abdominal pain—Aminophylline—asthma	0.000125	0.00115	CcSEcCtD
Naloxone—Body temperature increased—Aminophylline—asthma	0.000125	0.00115	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—asthma	0.000125	0.00114	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—asthma	0.000125	0.00114	CcSEcCtD
Naloxone—Agitation—Budesonide—asthma	0.000124	0.00114	CcSEcCtD
Naloxone—Asthenia—Ipratropium bromide—asthma	0.000124	0.00113	CcSEcCtD
Naloxone—Irritability—Hydrocortisone—asthma	0.000124	0.00113	CcSEcCtD
Naloxone—Nausea—Ciclesonide—asthma	0.000124	0.00113	CcSEcCtD
Naloxone—Dyspnoea—Flunisolide—asthma	0.000124	0.00113	CcSEcCtD
Naloxone—Cardiac arrest—Hydrocortisone—asthma	0.000124	0.00113	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—asthma	0.000123	0.00112	CcSEcCtD
Naloxone—Hypertension—Salbutamol—asthma	0.000121	0.0011	CcSEcCtD
Naloxone—Asthenia—Salmeterol—asthma	0.00012	0.0011	CcSEcCtD
Naloxone—Pain—Flunisolide—asthma	0.000119	0.00108	CcSEcCtD
Naloxone—Pulmonary oedema—Prednisone—asthma	0.000119	0.00108	CcSEcCtD
Naloxone—Abdominal pain—Loratadine—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Body temperature increased—Loratadine—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Nervous system disorder—Arformoterol—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Nervous system disorder—Formoterol—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Diarrhoea—Ipratropium bromide—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Abdominal pain—Tiotropium—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Tachycardia—Formoterol—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Tachycardia—Arformoterol—asthma	0.000118	0.00108	CcSEcCtD
Naloxone—Skin disorder—Formoterol—asthma	0.000117	0.00107	CcSEcCtD
Naloxone—Skin disorder—Arformoterol—asthma	0.000117	0.00107	CcSEcCtD
Naloxone—Hypertension—Budesonide—asthma	0.000117	0.00107	CcSEcCtD
Naloxone—Irritability—Methylprednisolone—asthma	0.000117	0.00106	CcSEcCtD
Naloxone—Cardiac arrest—Triamcinolone—asthma	0.000116	0.00106	CcSEcCtD
Naloxone—Hyperkinesia—Prednisone—asthma	0.000116	0.00106	CcSEcCtD
Naloxone—Cardiac arrest—Methylprednisolone—asthma	0.000116	0.00106	CcSEcCtD
Naloxone—Nervous system disorder—Montelukast—asthma	0.000116	0.00106	CcSEcCtD
Naloxone—Paraesthesia—Mometasone—asthma	0.000115	0.00106	CcSEcCtD
Naloxone—Skin disorder—Montelukast—asthma	0.000115	0.00105	CcSEcCtD
Naloxone—Dyspnoea—Mometasone—asthma	0.000115	0.00105	CcSEcCtD
Naloxone—Diarrhoea—Fluticasone Propionate—asthma	0.000115	0.00105	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Budesonide—asthma	0.000114	0.00105	CcSEcCtD
Naloxone—Diarrhoea—Salmeterol—asthma	0.000114	0.00104	CcSEcCtD
Naloxone—Nausea—Cromoglicic acid—asthma	0.000112	0.00103	CcSEcCtD
Naloxone—ABCB1—lung—asthma	0.000112	0.00635	CbGeAlD
Naloxone—Nervous system disorder—Salbutamol—asthma	0.000112	0.00102	CcSEcCtD
Naloxone—Tachycardia—Salbutamol—asthma	0.000111	0.00102	CcSEcCtD
Naloxone—Skin disorder—Salbutamol—asthma	0.000111	0.00101	CcSEcCtD
Naloxone—Hyperhidrosis—Salbutamol—asthma	0.00011	0.00101	CcSEcCtD
Naloxone—Vomiting—Ipratropium bromide—asthma	0.00011	0.00101	CcSEcCtD
Naloxone—Pain—Mometasone—asthma	0.00011	0.00101	CcSEcCtD
Naloxone—Abdominal pain—Flunisolide—asthma	0.00011	0.001	CcSEcCtD
Naloxone—Body temperature increased—Flunisolide—asthma	0.00011	0.001	CcSEcCtD
Naloxone—Diarrhoea—Aminophylline—asthma	0.000109	0.000992	CcSEcCtD
Naloxone—Nervous system disorder—Budesonide—asthma	0.000108	0.00099	CcSEcCtD
Naloxone—Tachycardia—Budesonide—asthma	0.000108	0.000985	CcSEcCtD
Naloxone—Dyspnoea—Arformoterol—asthma	0.000108	0.000984	CcSEcCtD
Naloxone—Dyspnoea—Formoterol—asthma	0.000108	0.000984	CcSEcCtD
Naloxone—Asthenia—Loratadine—asthma	0.000108	0.000983	CcSEcCtD
Naloxone—Skin disorder—Budesonide—asthma	0.000107	0.00098	CcSEcCtD
Naloxone—Hyperhidrosis—Budesonide—asthma	0.000107	0.000976	CcSEcCtD
Naloxone—Vomiting—Fluticasone Propionate—asthma	0.000106	0.000973	CcSEcCtD
Naloxone—Vomiting—Salmeterol—asthma	0.000106	0.000971	CcSEcCtD
Naloxone—Paraesthesia—Montelukast—asthma	0.000106	0.00097	CcSEcCtD
Naloxone—Irritability—Dexamethasone—asthma	0.000106	0.000968	CcSEcCtD
Naloxone—Irritability—Betamethasone—asthma	0.000106	0.000968	CcSEcCtD
Naloxone—Cardiac arrest—Betamethasone—asthma	0.000106	0.000965	CcSEcCtD
Naloxone—Cardiac arrest—Dexamethasone—asthma	0.000106	0.000965	CcSEcCtD
Naloxone—Gastrointestinal disorder—Formoterol—asthma	0.000104	0.000953	CcSEcCtD
Naloxone—Gastrointestinal disorder—Arformoterol—asthma	0.000104	0.000953	CcSEcCtD
Naloxone—Pain—Arformoterol—asthma	0.000103	0.000944	CcSEcCtD
Naloxone—Pain—Formoterol—asthma	0.000103	0.000944	CcSEcCtD
Naloxone—Nausea—Ipratropium bromide—asthma	0.000103	0.000939	CcSEcCtD
Naloxone—Diarrhoea—Loratadine—asthma	0.000103	0.000937	CcSEcCtD
Naloxone—Paraesthesia—Salbutamol—asthma	0.000102	0.000936	CcSEcCtD
Naloxone—Gastrointestinal disorder—Montelukast—asthma	0.000102	0.000933	CcSEcCtD
Naloxone—Abdominal pain—Mometasone—asthma	0.000102	0.000929	CcSEcCtD
Naloxone—Body temperature increased—Mometasone—asthma	0.000102	0.000929	CcSEcCtD
Naloxone—Dyspnoea—Salbutamol—asthma	0.000102	0.000929	CcSEcCtD
Naloxone—Pain—Montelukast—asthma	0.000101	0.000924	CcSEcCtD
Naloxone—Vomiting—Aminophylline—asthma	0.000101	0.000922	CcSEcCtD
Naloxone—Asthenia—Flunisolide—asthma	9.95e-05	0.000909	CcSEcCtD
Naloxone—Nausea—Fluticasone Propionate—asthma	9.95e-05	0.000909	CcSEcCtD
Naloxone—Nausea—Salmeterol—asthma	9.92e-05	0.000907	CcSEcCtD
Naloxone—Paraesthesia—Budesonide—asthma	9.92e-05	0.000906	CcSEcCtD
Naloxone—Dyspnoea—Budesonide—asthma	9.84e-05	0.0009	CcSEcCtD
Naloxone—Gastrointestinal disorder—Salbutamol—asthma	9.84e-05	0.000899	CcSEcCtD
Naloxone—Pain—Salbutamol—asthma	9.75e-05	0.000891	CcSEcCtD
Naloxone—Abdominal pain—Arformoterol—asthma	9.54e-05	0.000872	CcSEcCtD
Naloxone—Body temperature increased—Arformoterol—asthma	9.54e-05	0.000872	CcSEcCtD
Naloxone—Body temperature increased—Formoterol—asthma	9.54e-05	0.000872	CcSEcCtD
Naloxone—Abdominal pain—Formoterol—asthma	9.54e-05	0.000872	CcSEcCtD
Naloxone—Gastrointestinal disorder—Budesonide—asthma	9.53e-05	0.000871	CcSEcCtD
Naloxone—Vomiting—Loratadine—asthma	9.53e-05	0.000871	CcSEcCtD
Naloxone—Vomiting—Tiotropium—asthma	9.51e-05	0.000869	CcSEcCtD
Naloxone—Diarrhoea—Flunisolide—asthma	9.49e-05	0.000867	CcSEcCtD
Naloxone—Pain—Budesonide—asthma	9.44e-05	0.000863	CcSEcCtD
Naloxone—Nausea—Aminophylline—asthma	9.42e-05	0.000861	CcSEcCtD
Naloxone—Abdominal pain—Montelukast—asthma	9.35e-05	0.000854	CcSEcCtD
Naloxone—Body temperature increased—Montelukast—asthma	9.35e-05	0.000854	CcSEcCtD
Naloxone—Asthenia—Mometasone—asthma	9.23e-05	0.000843	CcSEcCtD
Naloxone—Irritability—Prednisone—asthma	9.23e-05	0.000843	CcSEcCtD
Naloxone—Cardiac arrest—Prednisone—asthma	9.19e-05	0.00084	CcSEcCtD
Naloxone—Sweating—Methylprednisolone—asthma	9.02e-05	0.000824	CcSEcCtD
Naloxone—Abdominal pain—Salbutamol—asthma	9.01e-05	0.000824	CcSEcCtD
Naloxone—Body temperature increased—Salbutamol—asthma	9.01e-05	0.000824	CcSEcCtD
Naloxone—Hallucination—Hydrocortisone—asthma	8.94e-05	0.000817	CcSEcCtD
Naloxone—Nausea—Loratadine—asthma	8.9e-05	0.000814	CcSEcCtD
Naloxone—Nausea—Tiotropium—asthma	8.89e-05	0.000812	CcSEcCtD
Naloxone—Vomiting—Flunisolide—asthma	8.82e-05	0.000806	CcSEcCtD
Naloxone—Diarrhoea—Mometasone—asthma	8.8e-05	0.000804	CcSEcCtD
Naloxone—Abdominal pain—Budesonide—asthma	8.73e-05	0.000798	CcSEcCtD
Naloxone—Body temperature increased—Budesonide—asthma	8.73e-05	0.000798	CcSEcCtD
Naloxone—Asthenia—Arformoterol—asthma	8.66e-05	0.000792	CcSEcCtD
Naloxone—Asthenia—Formoterol—asthma	8.66e-05	0.000792	CcSEcCtD
Naloxone—Asthenia—Montelukast—asthma	8.48e-05	0.000775	CcSEcCtD
Naloxone—Hallucination—Methylprednisolone—asthma	8.4e-05	0.000768	CcSEcCtD
Naloxone—Diarrhoea—Formoterol—asthma	8.26e-05	0.000755	CcSEcCtD
Naloxone—Diarrhoea—Arformoterol—asthma	8.26e-05	0.000755	CcSEcCtD
Naloxone—Nausea—Flunisolide—asthma	8.24e-05	0.000753	CcSEcCtD
Naloxone—Asthenia—Salbutamol—asthma	8.18e-05	0.000748	CcSEcCtD
Naloxone—Vomiting—Mometasone—asthma	8.18e-05	0.000747	CcSEcCtD
Naloxone—Diarrhoea—Montelukast—asthma	8.09e-05	0.000739	CcSEcCtD
Naloxone—Asthenia—Budesonide—asthma	7.92e-05	0.000724	CcSEcCtD
Naloxone—Mental disorder—Hydrocortisone—asthma	7.87e-05	0.00072	CcSEcCtD
Naloxone—Cardiac disorder—Methylprednisolone—asthma	7.84e-05	0.000716	CcSEcCtD
Naloxone—Diarrhoea—Salbutamol—asthma	7.8e-05	0.000713	CcSEcCtD
Naloxone—Vomiting—Arformoterol—asthma	7.68e-05	0.000702	CcSEcCtD
Naloxone—Vomiting—Formoterol—asthma	7.68e-05	0.000702	CcSEcCtD
Naloxone—Angiopathy—Methylprednisolone—asthma	7.66e-05	0.0007	CcSEcCtD
Naloxone—Hallucination—Betamethasone—asthma	7.64e-05	0.000698	CcSEcCtD
Naloxone—Hallucination—Dexamethasone—asthma	7.64e-05	0.000698	CcSEcCtD
Naloxone—Nausea—Mometasone—asthma	7.64e-05	0.000698	CcSEcCtD
Naloxone—Mediastinal disorder—Methylprednisolone—asthma	7.61e-05	0.000696	CcSEcCtD
Naloxone—Diarrhoea—Budesonide—asthma	7.56e-05	0.000691	CcSEcCtD
Naloxone—Vomiting—Montelukast—asthma	7.52e-05	0.000687	CcSEcCtD
Naloxone—Depression—Prednisone—asthma	7.43e-05	0.000679	CcSEcCtD
Naloxone—Mental disorder—Methylprednisolone—asthma	7.4e-05	0.000676	CcSEcCtD
Naloxone—Vomiting—Salbutamol—asthma	7.25e-05	0.000662	CcSEcCtD
Naloxone—Nausea—Arformoterol—asthma	7.17e-05	0.000655	CcSEcCtD
Naloxone—Nausea—Formoterol—asthma	7.17e-05	0.000655	CcSEcCtD
Naloxone—Nausea—Montelukast—asthma	7.02e-05	0.000642	CcSEcCtD
Naloxone—Vomiting—Budesonide—asthma	7.02e-05	0.000642	CcSEcCtD
Naloxone—Angiopathy—Dexamethasone—asthma	6.97e-05	0.000637	CcSEcCtD
Naloxone—Angiopathy—Betamethasone—asthma	6.97e-05	0.000637	CcSEcCtD
Naloxone—Convulsion—Prednisolone—asthma	6.94e-05	0.000634	CcSEcCtD
Naloxone—Hypertension—Prednisolone—asthma	6.92e-05	0.000632	CcSEcCtD
Naloxone—Convulsion—Hydrocortisone—asthma	6.78e-05	0.00062	CcSEcCtD
Naloxone—Nausea—Salbutamol—asthma	6.77e-05	0.000619	CcSEcCtD
Naloxone—Hypertension—Hydrocortisone—asthma	6.76e-05	0.000617	CcSEcCtD
Naloxone—Hallucination—Prednisone—asthma	6.65e-05	0.000608	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.62e-05	0.000605	CcSEcCtD
Naloxone—Nausea—Budesonide—asthma	6.56e-05	0.000599	CcSEcCtD
Naloxone—Convulsion—Triamcinolone—asthma	6.38e-05	0.000583	CcSEcCtD
Naloxone—Tachycardia—Prednisolone—asthma	6.38e-05	0.000583	CcSEcCtD
Naloxone—Convulsion—Methylprednisolone—asthma	6.37e-05	0.000582	CcSEcCtD
Naloxone—Hypertension—Triamcinolone—asthma	6.36e-05	0.000581	CcSEcCtD
Naloxone—Hypertension—Methylprednisolone—asthma	6.35e-05	0.00058	CcSEcCtD
Naloxone—Hyperhidrosis—Prednisolone—asthma	6.32e-05	0.000578	CcSEcCtD
Naloxone—Nervous system disorder—Hydrocortisone—asthma	6.26e-05	0.000572	CcSEcCtD
Naloxone—Tachycardia—Hydrocortisone—asthma	6.23e-05	0.00057	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	6.22e-05	0.000568	CcSEcCtD
Naloxone—Flushing—Prednisone—asthma	6.21e-05	0.000567	CcSEcCtD
Naloxone—Skin disorder—Hydrocortisone—asthma	6.2e-05	0.000567	CcSEcCtD
Naloxone—Hyperhidrosis—Hydrocortisone—asthma	6.17e-05	0.000564	CcSEcCtD
Naloxone—Angiopathy—Prednisone—asthma	6.07e-05	0.000555	CcSEcCtD
Naloxone—Nervous system disorder—Methylprednisolone—asthma	5.88e-05	0.000538	CcSEcCtD
Naloxone—Paraesthesia—Prednisolone—asthma	5.87e-05	0.000537	CcSEcCtD
Naloxone—Tachycardia—Triamcinolone—asthma	5.87e-05	0.000536	CcSEcCtD
Naloxone—Mental disorder—Prednisone—asthma	5.86e-05	0.000535	CcSEcCtD
Naloxone—Tachycardia—Methylprednisolone—asthma	5.86e-05	0.000535	CcSEcCtD
Naloxone—Skin disorder—Methylprednisolone—asthma	5.83e-05	0.000533	CcSEcCtD
Naloxone—Hyperhidrosis—Triamcinolone—asthma	5.81e-05	0.000531	CcSEcCtD
Naloxone—Hyperhidrosis—Methylprednisolone—asthma	5.8e-05	0.00053	CcSEcCtD
Naloxone—Convulsion—Dexamethasone—asthma	5.79e-05	0.000529	CcSEcCtD
Naloxone—Convulsion—Betamethasone—asthma	5.79e-05	0.000529	CcSEcCtD
Naloxone—Hypertension—Betamethasone—asthma	5.77e-05	0.000527	CcSEcCtD
Naloxone—Hypertension—Dexamethasone—asthma	5.77e-05	0.000527	CcSEcCtD
Naloxone—Paraesthesia—Hydrocortisone—asthma	5.73e-05	0.000524	CcSEcCtD
Naloxone—Pain—Prednisolone—asthma	5.59e-05	0.000511	CcSEcCtD
Naloxone—Gastrointestinal disorder—Hydrocortisone—asthma	5.51e-05	0.000504	CcSEcCtD
Naloxone—Pain—Hydrocortisone—asthma	5.46e-05	0.000499	CcSEcCtD
Naloxone—Paraesthesia—Triamcinolone—asthma	5.4e-05	0.000493	CcSEcCtD
Naloxone—Paraesthesia—Methylprednisolone—asthma	5.39e-05	0.000492	CcSEcCtD
Naloxone—Dyspnoea—Triamcinolone—asthma	5.36e-05	0.00049	CcSEcCtD
Naloxone—Nervous system disorder—Dexamethasone—asthma	5.35e-05	0.000489	CcSEcCtD
Naloxone—Nervous system disorder—Betamethasone—asthma	5.35e-05	0.000489	CcSEcCtD
Naloxone—Agitation—Prednisone—asthma	5.35e-05	0.000489	CcSEcCtD
Naloxone—Tachycardia—Dexamethasone—asthma	5.32e-05	0.000487	CcSEcCtD
Naloxone—Tachycardia—Betamethasone—asthma	5.32e-05	0.000487	CcSEcCtD
Naloxone—Hyperhidrosis—Dexamethasone—asthma	5.27e-05	0.000482	CcSEcCtD
Naloxone—Hyperhidrosis—Betamethasone—asthma	5.27e-05	0.000482	CcSEcCtD
Naloxone—Pain—Triamcinolone—asthma	5.14e-05	0.00047	CcSEcCtD
Naloxone—Abdominal pain—Hydrocortisone—asthma	5.05e-05	0.000461	CcSEcCtD
Naloxone—Body temperature increased—Hydrocortisone—asthma	5.05e-05	0.000461	CcSEcCtD
Naloxone—Convulsion—Prednisone—asthma	5.04e-05	0.000461	CcSEcCtD
Naloxone—Hypertension—Prednisone—asthma	5.03e-05	0.000459	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.92e-05	0.00045	CcSEcCtD
Naloxone—Paraesthesia—Dexamethasone—asthma	4.9e-05	0.000448	CcSEcCtD
Naloxone—Paraesthesia—Betamethasone—asthma	4.9e-05	0.000448	CcSEcCtD
Naloxone—Body temperature increased—Triamcinolone—asthma	4.75e-05	0.000434	CcSEcCtD
Naloxone—Abdominal pain—Methylprednisolone—asthma	4.74e-05	0.000433	CcSEcCtD
Naloxone—Gastrointestinal disorder—Dexamethasone—asthma	4.71e-05	0.00043	CcSEcCtD
Naloxone—Gastrointestinal disorder—Betamethasone—asthma	4.71e-05	0.00043	CcSEcCtD
Naloxone—Pain—Dexamethasone—asthma	4.67e-05	0.000426	CcSEcCtD
Naloxone—Pain—Betamethasone—asthma	4.67e-05	0.000426	CcSEcCtD
Naloxone—Nervous system disorder—Prednisone—asthma	4.66e-05	0.000426	CcSEcCtD
Naloxone—Tachycardia—Prednisone—asthma	4.64e-05	0.000424	CcSEcCtD
Naloxone—Skin disorder—Prednisone—asthma	4.62e-05	0.000422	CcSEcCtD
Naloxone—Hyperhidrosis—Prednisone—asthma	4.59e-05	0.00042	CcSEcCtD
Naloxone—Asthenia—Hydrocortisone—asthma	4.58e-05	0.000419	CcSEcCtD
Naloxone—Diarrhoea—Hydrocortisone—asthma	4.37e-05	0.000399	CcSEcCtD
Naloxone—Asthenia—Triamcinolone—asthma	4.31e-05	0.000394	CcSEcCtD
Naloxone—Abdominal pain—Betamethasone—asthma	4.31e-05	0.000394	CcSEcCtD
Naloxone—Body temperature increased—Betamethasone—asthma	4.31e-05	0.000394	CcSEcCtD
Naloxone—Body temperature increased—Dexamethasone—asthma	4.31e-05	0.000394	CcSEcCtD
Naloxone—Abdominal pain—Dexamethasone—asthma	4.31e-05	0.000394	CcSEcCtD
Naloxone—Asthenia—Methylprednisolone—asthma	4.3e-05	0.000393	CcSEcCtD
Naloxone—Paraesthesia—Prednisone—asthma	4.27e-05	0.00039	CcSEcCtD
Naloxone—Diarrhoea—Methylprednisolone—asthma	4.1e-05	0.000375	CcSEcCtD
Naloxone—Vomiting—Hydrocortisone—asthma	4.06e-05	0.000371	CcSEcCtD
Naloxone—Asthenia—Dexamethasone—asthma	3.91e-05	0.000358	CcSEcCtD
Naloxone—Asthenia—Betamethasone—asthma	3.91e-05	0.000358	CcSEcCtD
Naloxone—Nausea—Prednisolone—asthma	3.88e-05	0.000355	CcSEcCtD
Naloxone—Vomiting—Triamcinolone—asthma	3.82e-05	0.000349	CcSEcCtD
Naloxone—Vomiting—Methylprednisolone—asthma	3.81e-05	0.000349	CcSEcCtD
Naloxone—Nausea—Hydrocortisone—asthma	3.79e-05	0.000347	CcSEcCtD
Naloxone—Abdominal pain—Prednisone—asthma	3.76e-05	0.000343	CcSEcCtD
Naloxone—Body temperature increased—Prednisone—asthma	3.76e-05	0.000343	CcSEcCtD
Naloxone—Diarrhoea—Dexamethasone—asthma	3.73e-05	0.000341	CcSEcCtD
Naloxone—Diarrhoea—Betamethasone—asthma	3.73e-05	0.000341	CcSEcCtD
Naloxone—Nausea—Triamcinolone—asthma	3.57e-05	0.000326	CcSEcCtD
Naloxone—Nausea—Methylprednisolone—asthma	3.56e-05	0.000326	CcSEcCtD
Naloxone—Vomiting—Betamethasone—asthma	3.47e-05	0.000317	CcSEcCtD
Naloxone—Vomiting—Dexamethasone—asthma	3.47e-05	0.000317	CcSEcCtD
Naloxone—Asthenia—Prednisone—asthma	3.41e-05	0.000312	CcSEcCtD
Naloxone—Diarrhoea—Prednisone—asthma	3.25e-05	0.000297	CcSEcCtD
Naloxone—Nausea—Betamethasone—asthma	3.24e-05	0.000296	CcSEcCtD
Naloxone—Nausea—Dexamethasone—asthma	3.24e-05	0.000296	CcSEcCtD
Naloxone—Vomiting—Prednisone—asthma	3.02e-05	0.000276	CcSEcCtD
Naloxone—Nausea—Prednisone—asthma	2.82e-05	0.000258	CcSEcCtD
Naloxone—ESR1—Signaling Pathways—ADCY2—asthma	4.23e-06	3.85e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ADRB2—asthma	4.23e-06	3.85e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL3—asthma	4.21e-06	3.83e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—LEP—asthma	4.16e-06	3.78e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—LEP—asthma	4.15e-06	3.77e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CARM1—asthma	4.14e-06	3.77e-05	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IL6—asthma	4.12e-06	3.75e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CARM1—asthma	4.12e-06	3.74e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1B—asthma	4.1e-06	3.73e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—CD4—asthma	4.1e-06	3.73e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CXCL8—asthma	4.09e-06	3.72e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL2—asthma	4.09e-06	3.72e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—DCN—asthma	4.08e-06	3.71e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—asthma	4.07e-06	3.7e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PPP2CA—asthma	4.07e-06	3.7e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—DCN—asthma	4.06e-06	3.69e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ITPR1—asthma	4e-06	3.64e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR5—asthma	4e-06	3.63e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KNG1—asthma	3.98e-06	3.62e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALDH2—asthma	3.97e-06	3.61e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AGTR1—asthma	3.95e-06	3.59e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ALDH2—asthma	3.95e-06	3.59e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL2RA—asthma	3.94e-06	3.58e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—RHOA—asthma	3.94e-06	3.58e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FN1—asthma	3.92e-06	3.57e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FN1—asthma	3.91e-06	3.56e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL2—asthma	3.91e-06	3.55e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—C3—asthma	3.91e-06	3.55e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL10—asthma	3.86e-06	3.51e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—PTEN—asthma	3.84e-06	3.5e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—asthma	3.82e-06	3.47e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ARG1—asthma	3.81e-06	3.47e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CD86—asthma	3.81e-06	3.46e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SERPINE1—asthma	3.81e-06	3.46e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CXCL8—asthma	3.81e-06	3.46e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PDGFB—asthma	3.8e-06	3.46e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—POMC—asthma	3.8e-06	3.45e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NTRK1—asthma	3.79e-06	3.45e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALOX5—asthma	3.78e-06	3.44e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EDN1—asthma	3.78e-06	3.44e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GSTT1—asthma	3.78e-06	3.43e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GSTT1—asthma	3.75e-06	3.41e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCL5—asthma	3.75e-06	3.41e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ADRB2—asthma	3.75e-06	3.41e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PLA2G4A—asthma	3.73e-06	3.4e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CSF2—asthma	3.69e-06	3.36e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—RHOA—asthma	3.67e-06	3.34e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—IL2—asthma	3.64e-06	3.31e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—LEP—asthma	3.64e-06	3.31e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS3—asthma	3.64e-06	3.31e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CARM1—asthma	3.61e-06	3.28e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SMAD3—asthma	3.59e-06	3.27e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—POMC—asthma	3.57e-06	3.25e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—POMC—asthma	3.56e-06	3.24e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—DCN—asthma	3.56e-06	3.23e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—PTEN—asthma	3.55e-06	3.23e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ITPR1—asthma	3.55e-06	3.22e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCL2—asthma	3.5e-06	3.18e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6R—asthma	3.49e-06	3.17e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCL2—asthma	3.48e-06	3.17e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	3.48e-06	3.16e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6R—asthma	3.47e-06	3.16e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—POMC—asthma	3.46e-06	3.15e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALDH2—asthma	3.46e-06	3.15e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CXCL8—asthma	3.46e-06	3.14e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALDH7A1—asthma	3.45e-06	3.14e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PPP2CA—asthma	3.44e-06	3.13e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—STAT3—asthma	3.44e-06	3.13e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FN1—asthma	3.43e-06	3.12e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EGFR—asthma	3.42e-06	3.11e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EGFR—asthma	3.41e-06	3.1e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR5—asthma	3.38e-06	3.07e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CD86—asthma	3.38e-06	3.07e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EDN1—asthma	3.35e-06	3.05e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL2RA—asthma	3.33e-06	3.03e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL5—asthma	3.32e-06	3.02e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PLA2G4A—asthma	3.31e-06	3.01e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ARG2—asthma	3.31e-06	3.01e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL2—asthma	3.3e-06	3e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—C3—asthma	3.3e-06	3e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GSTT1—asthma	3.29e-06	2.99e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—SERPINE1—asthma	3.29e-06	2.99e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CSF2—asthma	3.27e-06	2.98e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SERPINE1—asthma	3.26e-06	2.97e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SERPINE1—asthma	3.25e-06	2.96e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PDGFB—asthma	3.21e-06	2.92e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SMAD3—asthma	3.19e-06	2.9e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—STAT3—asthma	3.17e-06	2.89e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ALB—asthma	3.15e-06	2.87e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RHOA—asthma	3.15e-06	2.86e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RHOA—asthma	3.14e-06	2.85e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NQO1—asthma	3.14e-06	2.85e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—EGFR—asthma	3.12e-06	2.84e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—POMC—asthma	3.12e-06	2.84e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—NQO1—asthma	3.12e-06	2.84e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOS3—asthma	3.12e-06	2.83e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOS3—asthma	3.11e-06	2.83e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IL2—asthma	3.08e-06	2.8e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—LEP—asthma	3.07e-06	2.79e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ADCY2—asthma	3.07e-06	2.79e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCL2—asthma	3.06e-06	2.78e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ADCY2—asthma	3.05e-06	2.78e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PPP2CA—asthma	3.05e-06	2.77e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6R—asthma	3.05e-06	2.77e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.04e-06	2.77e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.03e-06	2.75e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—NOS3—asthma	3.02e-06	2.74e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR5—asthma	2.99e-06	2.72e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EGFR—asthma	2.99e-06	2.72e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL2RA—asthma	2.95e-06	2.68e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—asthma	2.94e-06	2.68e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—C3—asthma	2.93e-06	2.66e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FN1—asthma	2.9e-06	2.64e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—EGFR—asthma	2.89e-06	2.62e-05	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ALB—asthma	2.88e-06	2.62e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SERPINE1—asthma	2.85e-06	2.59e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PDGFB—asthma	2.85e-06	2.59e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CXCL8—asthma	2.76e-06	2.51e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—asthma	2.76e-06	2.51e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CXCL8—asthma	2.76e-06	2.51e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RHOA—asthma	2.75e-06	2.5e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALOX5AP—asthma	2.74e-06	2.49e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALOX15—asthma	2.74e-06	2.49e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NQO1—asthma	2.73e-06	2.49e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—LEP—asthma	2.72e-06	2.48e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOS3—asthma	2.72e-06	2.48e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ADCY2—asthma	2.68e-06	2.43e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	2.66e-06	2.41e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL2—asthma	2.64e-06	2.4e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTEN—asthma	2.64e-06	2.4e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—POMC—asthma	2.64e-06	2.4e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL2—asthma	2.63e-06	2.39e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—asthma	2.63e-06	2.39e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—asthma	2.62e-06	2.38e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—VEGFA—asthma	2.62e-06	2.38e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GSTP1—asthma	2.62e-06	2.38e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CHAT—asthma	2.61e-06	2.38e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GSTP1—asthma	2.6e-06	2.37e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCL2—asthma	2.58e-06	2.35e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—HMOX1—asthma	2.58e-06	2.35e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ITPR1—asthma	2.58e-06	2.34e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6R—asthma	2.57e-06	2.34e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FN1—asthma	2.57e-06	2.34e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—HMOX1—asthma	2.57e-06	2.33e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ITPR1—asthma	2.56e-06	2.33e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CAT—asthma	2.55e-06	2.32e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CAT—asthma	2.53e-06	2.3e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—EGFR—asthma	2.53e-06	2.3e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—asthma	2.5e-06	2.27e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—asthma	2.49e-06	2.27e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTEN—asthma	2.49e-06	2.26e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTEN—asthma	2.48e-06	2.25e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCL8—asthma	2.42e-06	2.2e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SERPINE1—asthma	2.41e-06	2.19e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTEN—asthma	2.41e-06	2.19e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GSTM1—asthma	2.4e-06	2.19e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PLA2G4A—asthma	2.4e-06	2.19e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—asthma	2.4e-06	2.19e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—asthma	2.4e-06	2.18e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GSTM1—asthma	2.39e-06	2.17e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PLA2G4A—asthma	2.39e-06	2.17e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—POMC—asthma	2.34e-06	2.13e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALOX5—asthma	2.33e-06	2.12e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RHOA—asthma	2.33e-06	2.12e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL2—asthma	2.31e-06	2.1e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOS3—asthma	2.3e-06	2.09e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—asthma	2.3e-06	2.09e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL2—asthma	2.29e-06	2.08e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6R—asthma	2.28e-06	2.08e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GSTP1—asthma	2.28e-06	2.07e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—HMOX1—asthma	2.25e-06	2.05e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VEGFA—asthma	2.24e-06	2.04e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ITPR1—asthma	2.24e-06	2.04e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VEGFA—asthma	2.24e-06	2.04e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—STAT3—asthma	2.22e-06	2.02e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CARM1—asthma	2.22e-06	2.02e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CAT—asthma	2.22e-06	2.02e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—asthma	2.22e-06	2.02e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—STAT3—asthma	2.22e-06	2.02e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PPP2CA—asthma	2.21e-06	2.01e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PPP2CA—asthma	2.2e-06	2e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—DCN—asthma	2.19e-06	1.99e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—asthma	2.19e-06	1.99e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTEN—asthma	2.17e-06	1.98e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SERPINE1—asthma	2.14e-06	1.94e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALDH2—asthma	2.13e-06	1.94e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PLA2G4A—asthma	2.1e-06	1.91e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GSTM1—asthma	2.1e-06	1.91e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RHOA—asthma	2.06e-06	1.88e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—asthma	2.06e-06	1.87e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—asthma	2.05e-06	1.87e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCL8—asthma	2.04e-06	1.86e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOS3—asthma	2.04e-06	1.86e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GSTT1—asthma	2.03e-06	1.84e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EGFR—asthma	2.02e-06	1.84e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EGFR—asthma	2.01e-06	1.83e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VEGFA—asthma	1.96e-06	1.78e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL2—asthma	1.95e-06	1.77e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—STAT3—asthma	1.94e-06	1.77e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—asthma	1.94e-06	1.77e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PPP2CA—asthma	1.93e-06	1.75e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—asthma	1.85e-06	1.68e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTEN—asthma	1.84e-06	1.67e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL8—asthma	1.81e-06	1.65e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—asthma	1.8e-06	1.64e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EGFR—asthma	1.77e-06	1.61e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL2—asthma	1.73e-06	1.57e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—POMC—asthma	1.7e-06	1.55e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—POMC—asthma	1.69e-06	1.54e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NQO1—asthma	1.68e-06	1.53e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VEGFA—asthma	1.66e-06	1.51e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ADCY2—asthma	1.65e-06	1.5e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—STAT3—asthma	1.64e-06	1.49e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—asthma	1.64e-06	1.49e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTEN—asthma	1.63e-06	1.48e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—asthma	1.55e-06	1.41e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALB—asthma	1.55e-06	1.41e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—asthma	1.55e-06	1.41e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—asthma	1.52e-06	1.38e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EGFR—asthma	1.49e-06	1.36e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NOS3—asthma	1.48e-06	1.35e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—POMC—asthma	1.48e-06	1.35e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—NOS3—asthma	1.47e-06	1.34e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VEGFA—asthma	1.47e-06	1.34e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—STAT3—asthma	1.46e-06	1.32e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GSTP1—asthma	1.4e-06	1.28e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HMOX1—asthma	1.39e-06	1.26e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ITPR1—asthma	1.38e-06	1.26e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CAT—asthma	1.37e-06	1.24e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—asthma	1.36e-06	1.23e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—asthma	1.36e-06	1.23e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALB—asthma	1.35e-06	1.23e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—asthma	1.35e-06	1.23e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—asthma	1.35e-06	1.23e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EGFR—asthma	1.32e-06	1.2e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NOS3—asthma	1.29e-06	1.17e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PLA2G4A—asthma	1.29e-06	1.17e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GSTM1—asthma	1.29e-06	1.17e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPP2CA—asthma	1.19e-06	1.08e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTEN—asthma	1.18e-06	1.08e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—asthma	1.18e-06	1.07e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTEN—asthma	1.18e-06	1.07e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—asthma	1.15e-06	1.04e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTEN—asthma	1.03e-06	9.37e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—asthma	1.02e-06	9.25e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—POMC—asthma	9.12e-07	8.3e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALB—asthma	8.32e-07	7.57e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NOS3—asthma	7.96e-07	7.24e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—asthma	7.28e-07	6.62e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTEN—asthma	6.35e-07	5.77e-06	CbGpPWpGaD
